PDF herunterladen
Synthesis 2011(17): 2733-2736  
DOI: 10.1055/s-0030-1260103
SPECIALTOPIC
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of 1,2,3-Triazole Elements in Histamine H3 Receptor Ligands

Miriam Walter, Tim Kottke, Lilia Weizel, J. Stephan Schwed, Holger Stark*
Johann Wolfgang Goethe University, Institute of Pharmaceutical Chemistry, Biocenter, ZAFES/OSF/NeFF/CMP/ICNF, Max-von-Laue-Str. 9, 60438 Frankfurt, Germany
Fax: +49(69)79829352; e-Mail: h.stark@pharmchem.uni-frankfurt.de;
Weitere Informationen

Publikationsverlauf

Received 25 February 2011
Publikationsdatum:
08. Juli 2011 (online)

   Lizenzen und Reprints Alle Artikel dieser Rubrik
Preview

Abstract

1,2,3-Triazole moieties were introduced in a histamine H3 receptor antagonist pharmacophore blueprint with a versatile click chemistry approach, yielding potent ligands. Azide and alkynes were combined under copper(I) catalysis to provide the triazole element. Conventional synthesis, as well as microwave irradiation, was successfully applied.

Key words

azides - alkynes - copper catalysis - click chemistry - histamine H3 receptor

    References

  • 1a Leurs R. Bakker RA. Timmerman H. de Esch IJ. Nat. Rev. Drug Discovery  2005,  4:  1070 
    Suche in Google Scholar
  • 1b Tiligada E. Zampeli E. Sander K. Stark H. Expert Opin. Invest. Drugs  2009,  18:  1519 
    Suche in Google Scholar
  • 2a Raddatz R. Tao M. Hudkins RL. Curr. Top. Med. Chem.  2010,  10:  153 
    Suche in Google Scholar
  • 2b Brioni JD. Esbenshade TA. Garrison TR. Bitner SR. Cowart MD. J. Pharmacol. Exp. Ther.  2011,  336:  38 
    Suche in Google Scholar
  • 2c Walter M. Stark H. Front. Biosci.  2011,  in press
  • 3a Celanire S. Wijtmans M. Talaga P. Leurs R. de Esch IJ. Drug Discovery Today  2005,  10:  1613 
    Suche in Google Scholar
  • 3b Celanire S. Lebon F. Stark H. In The Third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders   Vohora DS. Taylor & Francis, CRC Press Inc.; Boca Raton: 2008.  p.103 
  • 3c Sander K. von Coburg Y. Camelin JC. Ligneau X. Rau O. Schubert-Zsilavecz M. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2010,  20:  1581 
    Suche in Google Scholar
  • 4a Denonne F. Atienzar F. Celanire S. Christophe B. Delannois F. Delaunoy C. Delporte ML. Durieu V. Gillard M. Lallemand B. Lamberty Y. Lorent G. Vanbellinghen A. Van Houtvin N. Verbois V. Provins L. ChemMedChem  2010,  5:  206 
    Suche in Google Scholar
  • 4b Davenport AJ. Stimson CC. Corsi M. Vaidya D. Glenn E. Jones TD. Bailey S. Gemkow MJ. Fritz U. Hallett DJ. Bioorg. Med. Chem. Lett.  2010,  20:  5165 
    Suche in Google Scholar
  • 4c Rao AU. Palani A. Chen X. Huang Y. Aslanian RG. West RE. Williams SM. Wu RL. Hwa J. Sondey C. Lachowicz J. Bioorg. Med. Chem. Lett.  2009,  19:  6176 
    Suche in Google Scholar
  • 4d Swanson DM. Shah CR. Lord B. Morton K. Dvorak LK. Mazur C. Apodaca R. Xiao W. Boggs JD. Feinstein M. Wilson SJ. Barbier AJ. Bonaventure P. Lovenberg TW. Carruthers NI. Eur. J. Med. Chem.  2009,  44:  4413 
    Suche in Google Scholar
  • 4e Celanire S. Wijtmans M. Christophe B. Collart P. de Esch I. Dassesse D. Delaunoy C. Denonne F. Durieu V. Gelens E. Gillard M. Lallemand B. Lamberty Y. Lebon F. Nicolas JM. Quere L. Snip E. Vanbellinghen A. Van Houtvin N. Verbois V. Timmerman H. Talaga P. Leurs R. Provins L. ChemMedChem  2009,  4:  1063 
    Suche in Google Scholar
  • 4f Walter M. von Coburg Y. Isensee K. Sander K. Ligneau X. Camelin JC. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2010,  20:  5879 
    Suche in Google Scholar
  • 4g Walter M. Isensee K. Kottke T. Ligneau X. Camelin JC. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2010,  20:  5883 
    Suche in Google Scholar
  • 5 Huisgen R. In 1,3-Dipolar Cycloaddition Chemistry   Vol. 1:  Padwa A. Wiley; New York: 1984.  p.1 
    Suche in Google Scholar
  • 6 Rostovtsev VV. Green LG. Fokin VV. Sharpless KB. Angew. Chem. Int. Ed.  2002,  41:  2596 
    Suche in Google Scholar
  • 7 Kolb HC. Sharpless KB. Drug Discovery Today  2003,  8:  1128 
    CrossrefPubMedSuche in Google Scholar
  • 8 Sander K. Kottke T. Hoffend C. Walter M. Weizel L. Camelin JC. Ligneau X. Schneider EH. Seifert R. Schwartz JC. Stark H. Org. Lett.  2010,  12:  2578 
    CrossrefSuche in Google Scholar
  • 9a Ligneau X. Morisset S. Tardivel-Lacombe J. Gbahou F. Ganellin CR. Stark H. Schunack W. Schwartz JC. Arrang JM. Br. J. Pharmacol.  2000,  131:  1247 
    Suche in Google Scholar
  • 9b Ligneau X. Perrin D. Landais L. Camelin JC. Calmels TP. Berrebi-Bertrand I. Lecomte JM. Parmentier R. Anaclet C. Lin JS. Bertaina-Anglade V. la Rochelle CD. d’Aniello F. Rouleau A. Gbahou F. Arrang JM. Ganellin CR. Stark H. Schunack W. Schwartz JC. J. Pharmacol. Exp. Ther.  2007,  320:  365 
    Suche in Google Scholar
  • 10 Kottke T. Sander K. Weizel L. Schneider EH. Seifert R. Stark H. Eur. J. Pharmacol.  2011,  654:  200 
    CrossrefSuche in Google Scholar
  • 11 Rodionov VO. Fokin VV. Finn MG. Angew. Chem. Int. Ed.  2005,  44:  2210 
    CrossrefPubMedSuche in Google Scholar
  • 12a Amon M. Ligneau X. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2006,  16:  1938 
    Suche in Google Scholar
  • 12b Ju Y. Kumar D. Varma RS. J. Org. Chem.  2006,  71:  6697 
    Suche in Google Scholar
  • 12c Isensee K. Amon M. Galaparti A. Ligneau X. Camelin JC. Capet M. Schwartz JC. Stark H. Bioorg. Med. Chem. Lett.  2009,  19:  2172 
    Suche in Google Scholar
  • 13 Appukkuttan P. Dehaen W. Fokin VV. Van der Eycken E. Org. Lett.  2004,  6:  4223 
    CrossrefSuche in Google Scholar
  • 14 Hansen SG. Jensen HH. Synlett  2009,  3275 
    Thieme Connect